GlassScriptPhysician profile
Ziad Affas
NPI 1205413200
$3,113.00
in general payments reported to CMS, 2019-2025
24 companies · $2,045 in 2025
The $2,045 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $126 · 2024: $942 · 2025: $2,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,061 · Education: $52.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,061.00 |
| Education | $52.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $379.23 | 2024-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $364.57 | 2024-2025 | Assure Wcd |
| Chiesi USA, INC. | $263.14 | 2024-2025 | Kengreal, Cleviprex |
| Boston Scientific Corporation | $242.36 | 2025 | Avvigo Guidance System, Farapulse, Rotapro |
| Abiomed | $222.66 | 2025 | |
| Pfizer INC. | $215.46 | 2024-2025 | |
| Inari Medical, INC. | $179.73 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $175.49 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite, Amplatzer Talisman |
| Kiniksa Pharmaceuticals, LTD. | $126.00 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2024 | Xarelto |
| Philips North America LLC | $121.85 | 2025 | IV Other |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.52 | 2024 | Lifevest |
| Medtronic, INC. | $99.92 | 2024-2025 | In.Pact Admiral, Symplicity G3 |
| Bard Peripheral Vascular, INC. | $76.25 | 2025 | Denali Vena Cava Filter |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $73.78 | 2024-2025 | Wainua |
| Teleflex LLC | $52.85 | 2024-2025 | Guideliner, Turnpike |
| Kiniksa Pharmaceuticals International, Plc | $37.11 | 2024 | Arcalyst |
| Reflow Medical INC | $23.71 | 2025 | |
| Stryker Corporation | $20.60 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $20.58 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.26 | 2025 | Onpattro |
| Bridgebio Pharma, INC. | $18.46 | 2025 | Attruby |
| Inspiremd LTD | $14.48 | 2025 | Cguard Prime Carotid Stent System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Affas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.